Dawn Howard-Mistry, MSN, BSN, APN-C, is Elected to the American Health Council’s Board of Nurses
September 13, 2017 09:36 ET
|
American Health Council
NEW YORK, Sept. 13, 2017 (GLOBE NEWSWIRE) -- The American Health Council is proud to elect Mrs. Dawn Howard-Mistry, Transitions of Care Nurse Practitioner at Saint Barnabas Medical Center, to their...
Dr. Judith K. Glann, DNP/MSN/ACNP-BC/CCRN, is appointed to the American Health Council for Best in Nursing
August 21, 2017 08:00 ET
|
American Health Council
NEW YORK, Aug. 21, 2017 (GLOBE NEWSWIRE) -- Currently a Trauma/Surgical ICU Critical Care Nurse Practitioner at UW/Harborview Medical Center, Dr. Judith K. Glann, DNP, ACNP-BC, CCRN, is being...
ARCA biopharma Announces Completion of Enrollment for GENETIC-AF Phase 2B Clinical Trial
August 16, 2017 08:30 ET
|
ARCA Biopharma, Inc.
GENETIC-AF Evaluating Gencaro as Potentially First Genetically-Targeted Treatment for Atrial Fibrillation ARCA Estimates Reporting Top-line Phase 2B Data in the First Quarter of 2018 WESTMINSTER,...
ARCA biopharma Announces GENETIC-AF Data and Safety Monitoring Board Recommendation to Complete Phase 2B GENETIC-AF Clinical Trial Based on Efficacy and Safety Data in Phase 2B Interim Analysis
August 09, 2017 16:30 ET
|
ARCA Biopharma, Inc.
ARCA Estimates Reporting Top-line Phase 2B Data in the First Quarter of 2018Gencaro Development Program Has Been Granted Fast Track Designation by U.S. FDA WESTMINSTER, Colo., Aug. 09, 2017 (GLOBE...
American Health Council Names Edmund J. Miller, Ph.D. to Education Board
July 28, 2017 08:00 ET
|
American Health Council
NEW YORK, July 28, 2017 (GLOBE NEWSWIRE) -- Dr. Edmund J. Miller of The Feinstein Institute for Medical Research has been selected to join the Education Board at the American Health Council. He will...
Admera Health Partners with Helix to Launch Genetic Tests to Assess the Risk of Inherited High Cholesterol, Sudden Cardiac Death, and Inherited Diabetes
July 24, 2017 07:45 ET
|
Admera Health, LLC
SOUTH PLAINFIELD, N.J., July 24, 2017 (GLOBE NEWSWIRE) -- Admera Health, a molecular diagnostics company developing comprehensive genetic tests for the risk assessment and early diagnosis of...
New Study with Abiomed’s Impella 2.5® Heart Pump Demonstrates Potential Survival with Pre-PCI Insertion in Heart Attacks with the Left Main Coronary Artery
June 30, 2017 08:04 ET
|
Abiomed
DANVERS, Mass., June 30, 2017 (GLOBE NEWSWIRE) -- Abiomed, Inc. (NASDAQ:ABMD), a leading provider of breakthrough heart support and recovery technologies, announced today the recent publication of a...
Heart Recovery Patients Visit Capitol Hill to Advocate for Lifesaving Cardiovascular Technology
June 09, 2017 08:07 ET
|
Abiomed
WASHINGTON, June 09, 2017 (GLOBE NEWSWIRE) -- Nineteen patients who benefitted from treatment with Abiomed’s Impella heart pumps traveled to Washington, D.C. on June 8, 2017, to meet with elected...
ARCA Biopharma Announces First Quarter 2017 Financial Results and Provides Business Update
May 15, 2017 08:30 ET
|
ARCA Biopharma, Inc.
WESTMINSTER, Colo., May 15, 2017 (GLOBE NEWSWIRE) -- ARCA biopharma, Inc. (Nasdaq:ABIO), a biopharmaceutical company applying a precision medicine approach to developing genetically-targeted...
Abiomed Introduces 3rd Generation Impella CP® Heart Pumps at SCAI 2017
May 09, 2017 09:33 ET
|
Abiomed
DANVERS, Mass., May 09, 2017 (GLOBE NEWSWIRE) -- Abiomed, Inc. (NASDAQ:ABMD), a leading provider of breakthrough heart support and recovery technologies, announced the debut of the 3rd Generation...